ANI Pharmaceuticals (ANIP)

[Easka]

Thanks for the article. I like this line as well.
“Less than 10 percent of patients who could benefit from this therapy were benefited from it,” he noted. There may even be future indications that the drug could prove useful for, he said."
Art had talked about expanding the customer base for Corti. That was always the wild card that should come, to some degree with the large price reduction for the drug. Hopefully we get some comments on volume increases as well as forecasted revenue for the year, in the next CC.